Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 1/2017

01-01-2017 | Original Article

Influence of contraceptive choice on vaginal bacterial and fungal microflora

Authors: G. Donders, G. Bellen, D. Janssens, B. Van Bulck, P. Hinoul, J. Verguts

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 1/2017

Login to get access

Abstract

The influence of contraception on vaginal microflora can have a major impact on the risk of developing acute or recurrent vaginal infections, but also may influence the risk of acquiring sexually transmissible infections (STI) such as HIV. A cohort of 248 women presenting for levonorgestrel-releasing intrauterine system (LNG-IUS) insertion or reinsertion were stratified according to their current contraceptive method. Information concerning their menstrual pattern and data about the medical history were collected. The composition of their vaginal microflora was studied by detailed phase contrast microscopy of fresh vaginal fluid, and aerobic cultures were taken to detect enteric bacterial growth and fungal colonisation. LNG-IUS and progesterone-only-pill (POP) users had significantly lower blood loss (p < 0.001) than other women. Regardless of the type of contraception used, all women reported similar rates of symptomatic lower genital tract infection during the preceding year. Women using combined oral contraception (COC) and long-term LNG-IUS had the same bacterial composition of vaginal microflora as non-contraceptive users, even when infections were combined. Both hormonal and non-hormonal intrauterine device users had an increased tendency to have more vaginal colonisation with Candida. Women on POPs or subcutaneous implants had a tendency towards increased vaginal atrophy, but had a lower Candida carriage rate compared to IUCD users (LNG-IUS and Copper-IUCD, p = 0.037). Women with an increased risk of acquiring STIs or recurrent BV could benefit from LNG-IUS or COC due to a well-preserved vaginal bacterial flora. Women with a susceptibility for RVVC should prefer POPs, and avoid intrauterine contraception.
Literature
1.
go back to reference van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S (2008) Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. Contraception 77:122–129CrossRefPubMed van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S (2008) Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. Contraception 77:122–129CrossRefPubMed
2.
go back to reference Tibaldi C, Cappello N, Latino MA, Masuelli G, Marini S, Benedetto C (2009) Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect 15:670–679CrossRefPubMed Tibaldi C, Cappello N, Latino MA, Masuelli G, Marini S, Benedetto C (2009) Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: risk factors and rates of occurrence. Clin Microbiol Infect 15:670–679CrossRefPubMed
3.
go back to reference Schwebke JR (2005) Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis 192:1315–1317CrossRefPubMed Schwebke JR (2005) Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis 192:1315–1317CrossRefPubMed
4.
go back to reference Kumwenda NI, Kumwenda J, Kafulafula G, Makanani B, Taulo F, Nkhoma C et al (2008) HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS 19:339–341CrossRefPubMed Kumwenda NI, Kumwenda J, Kafulafula G, Makanani B, Taulo F, Nkhoma C et al (2008) HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS 19:339–341CrossRefPubMed
5.
go back to reference Pettifor A, Delany S, Kleinschmidt I, Miller WC, Atashili J, Rees H (2009) Use of injectable progestin contraception and risk of STI among South African women. Contraception 80:555–560CrossRefPubMedPubMedCentral Pettifor A, Delany S, Kleinschmidt I, Miller WC, Atashili J, Rees H (2009) Use of injectable progestin contraception and risk of STI among South African women. Contraception 80:555–560CrossRefPubMedPubMedCentral
6.
go back to reference Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E et al (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12:19–26CrossRefPubMed Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E et al (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12:19–26CrossRefPubMed
7.
go back to reference Donders GG (2007) Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21:355–373CrossRefPubMed Donders GG (2007) Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21:355–373CrossRefPubMed
8.
go back to reference Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109:34–43CrossRefPubMed Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109:34–43CrossRefPubMed
9.
go back to reference Donders GG, Berger J, Heuninckx H, Bellen G, Cornelis A (2011) Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device. Contraception 83:352–356CrossRefPubMed Donders GG, Berger J, Heuninckx H, Bellen G, Cornelis A (2011) Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device. Contraception 83:352–356CrossRefPubMed
10.
go back to reference Neale R, Knight I, Keane F (2009) Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device? Int J STD AIDS 20:423–424CrossRefPubMed Neale R, Knight I, Keane F (2009) Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device? Int J STD AIDS 20:423–424CrossRefPubMed
11.
go back to reference Roy S (1991) Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 165:1240–1244CrossRefPubMed Roy S (1991) Nonbarrier contraceptives and vaginitis and vaginosis. Am J Obstet Gynecol 165:1240–1244CrossRefPubMed
12.
go back to reference Haukkamaa M, Stranden P, Jousimies-Somer H, Siitonen A (1986) Bacterial flora of the cervix in women using different methods of contraception. Am J Obstet Gynecol 154:520–524CrossRefPubMed Haukkamaa M, Stranden P, Jousimies-Somer H, Siitonen A (1986) Bacterial flora of the cervix in women using different methods of contraception. Am J Obstet Gynecol 154:520–524CrossRefPubMed
13.
go back to reference Keane FE, Ison CA, Taylor-Robinson D (1997) A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 8:489–494CrossRefPubMed Keane FE, Ison CA, Taylor-Robinson D (1997) A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 8:489–494CrossRefPubMed
14.
go back to reference Hodoglugil NN, Aslan D, Bertan M (2000) Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception 61:359–364CrossRefPubMed Hodoglugil NN, Aslan D, Bertan M (2000) Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception 61:359–364CrossRefPubMed
15.
go back to reference Ferraz do LR, Simoes JA, Bahamondes L, Camargo RP, Perrotti M, Monteiro I (2003) Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections. Contraception 68:105–109CrossRef Ferraz do LR, Simoes JA, Bahamondes L, Camargo RP, Perrotti M, Monteiro I (2003) Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections. Contraception 68:105–109CrossRef
16.
go back to reference Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J et al (2010) A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sex Transm Dis 37:621–628PubMed Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J et al (2010) A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sex Transm Dis 37:621–628PubMed
17.
18.
go back to reference Lessard T, Simoes JA, Discacciati MG, Hidalgo M, Bahamondes L (2008) Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS). Contraception 77:30–33CrossRefPubMed Lessard T, Simoes JA, Discacciati MG, Hidalgo M, Bahamondes L (2008) Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS). Contraception 77:30–33CrossRefPubMed
19.
go back to reference Toppozada M, Amer S, el-Ghazzawi E (1986) Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis. Adv Contracept 2:117–122CrossRefPubMed Toppozada M, Amer S, el-Ghazzawi E (1986) Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis. Adv Contracept 2:117–122CrossRefPubMed
20.
go back to reference Spacek J, Buchta V, Jilek P, Forstl M (2007) Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur J Obstet Gynecol Reprod Biol 131:198–202CrossRefPubMed Spacek J, Buchta V, Jilek P, Forstl M (2007) Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur J Obstet Gynecol Reprod Biol 131:198–202CrossRefPubMed
21.
go back to reference Nohmi T, Abe S, Dobashi K, Tansho S, Yamaguchi H (1995) Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women’s vulnerability to vaginal candidiasis. Microbiol Immunol 39:405–409CrossRefPubMed Nohmi T, Abe S, Dobashi K, Tansho S, Yamaguchi H (1995) Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women’s vulnerability to vaginal candidiasis. Microbiol Immunol 39:405–409CrossRefPubMed
22.
go back to reference Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL (2004) Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 104:926–930CrossRefPubMed Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL (2004) Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 104:926–930CrossRefPubMed
Metadata
Title
Influence of contraceptive choice on vaginal bacterial and fungal microflora
Authors
G. Donders
G. Bellen
D. Janssens
B. Van Bulck
P. Hinoul
J. Verguts
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 1/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2768-8

Other articles of this Issue 1/2017

European Journal of Clinical Microbiology & Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.